NCT05653635View on ClinicalTrials.gov

Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

September 1, 2028

Study Completion Date

September 1, 2028

Conditions
Glioblastoma
Interventions
RADIATION

Simultaneous-integrated boost with IMRT

Simultaneous-integrated boost guided by FDOPA-PET

Trial Locations (1)

67033

Institut de cancérologie Strasbourg Europe, Strasbourg

All Listed Sponsors
collaborator

Centre Georges François Leclerc

UNKNOWN

lead

Institut de cancérologie Strasbourg Europe

OTHER